15 May 2012

Senate Hearing: James Love Testimony on the High Cost of High Prices for HIV/AIDs Drugs and the Prize Fund Alternative

The de-linkage of R&D costs and drug prices through the Prize Fund for HIV/AIDS will cost less, expand access, accelerate and improve innovation, and replace an incentive system that is expensive, inefficient and unsustainable. James Love’s testimony before Senate Subcommittee on Primary Health and Aging.